SELZENTRY (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the SELZENTRY drug offered from Pfizer Laboratories Div Pfizer Inc. This CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | Maraviroc |
| SUBSTANCE NAME: | MARAVIROC |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-08-06 |
| END MARKETING DATE: | 0000-00-00 |
SELZENTRY HUMAN PRESCRIPTION DRUG Details:
| Item Description | SELZENTRY from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2007-08-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-0807_091ac88c-36c9-45b5-8115-934c2b0dac42 |
| PRODUCT NDC: | 0069-0807 |
| APPLICATION NUMBER: | NDA022128 |
Other MARAVIROC Pharmaceutical Manufacturers / Labelers:
